The Urgent Need for Reliable Cell Models in ALS Research
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings
Press release: improving the early detection, prevention and treatment of lung disease